| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design
|
Morfouace, M.
|
|
2018
|
52 |
P2 |
p. 158-165
|
artikel
|
| 2 |
Biomarkers for checkpoint inhibition in hematologic malignancies
|
Atanackovic, Djordje
|
|
2018
|
52 |
P2 |
p. 198-206
|
artikel
|
| 3 |
Breast cancer genomics and immuno-oncological markers to guide immune therapies
|
Hammerl, D.
|
|
2018
|
52 |
P2 |
p. 178-188
|
artikel
|
| 4 |
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
|
Zhang, Dingxiao
|
|
2018
|
52 |
P2 |
p. 94-106
|
artikel
|
| 5 |
Editorial Board & Publication Information
|
|
|
2018
|
52 |
P2 |
p. IFC
|
artikel
|
| 6 |
Emerging biomarkers for cancer immunotherapy in melanoma
|
Axelrod, Margaret L.
|
|
2018
|
52 |
P2 |
p. 207-215
|
artikel
|
| 7 |
Emerging biomarkers for immune checkpoint inhibition in lung cancer
|
Cyriac, George
|
|
2018
|
52 |
P2 |
p. 269-277
|
artikel
|
| 8 |
Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers
|
Lee, Belinda
|
|
2018
|
52 |
P2 |
p. 241-252
|
artikel
|
| 9 |
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
|
Lhuillier, Claire
|
|
2018
|
52 |
P2 |
p. 125-134
|
artikel
|
| 10 |
Emerging targets in cancer immunotherapy
|
Burugu, Samantha
|
|
2018
|
52 |
P2 |
p. 39-52
|
artikel
|
| 11 |
Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment
|
Gevaert, Thomas
|
|
2018
|
52 |
P2 |
p. 216-227
|
artikel
|
| 12 |
Genomics and emerging biomarkers for immunotherapy of colorectal cancer
|
Kather, Jakob Nikolas
|
|
2018
|
52 |
P2 |
p. 189-197
|
artikel
|
| 13 |
Gyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors
|
Curigliano, Giuseppe
|
|
2018
|
52 |
P2 |
p. 253-258
|
artikel
|
| 14 |
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
|
Solomon, Benjamin
|
|
2018
|
52 |
P2 |
p. 228-240
|
artikel
|
| 15 |
Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy
|
van Dam, Pieter-Jan
|
|
2018
|
52 |
P2 |
p. 86-93
|
artikel
|
| 16 |
Immuno-oncology from the perspective of somatic evolution
|
González, Santiago
|
|
2018
|
52 |
P2 |
p. 75-85
|
artikel
|
| 17 |
Immuno-oncology-101: overview of major concepts and translational perspectives
|
Allard, B.
|
|
2018
|
52 |
P2 |
p. 1-11
|
artikel
|
| 18 |
In the beginning, there was chaos: A perspective on the development of immuno-oncological biomarkers
|
Salgado, Roberto
|
|
2018
|
52 |
P2 |
p. v-vi
|
artikel
|
| 19 |
Network science in clinical trials: A patient-centered approach
|
Manem, Venkata S.K.
|
|
2018
|
52 |
P2 |
p. 135-150
|
artikel
|
| 20 |
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective
|
Nallasamy, Palanisamy
|
|
2018
|
52 |
P2 |
p. 53-65
|
artikel
|
| 21 |
Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting
|
Vermaelen, K.
|
|
2018
|
52 |
P2 |
p. 166-177
|
artikel
|
| 22 |
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
|
Hegde, Priti S.
|
|
2018
|
52 |
P2 |
p. 117-124
|
artikel
|
| 23 |
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment
|
Passiglia, F.
|
|
2018
|
52 |
P2 |
p. 259-268
|
artikel
|
| 24 |
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
|
Klauschen, F.
|
|
2018
|
52 |
P2 |
p. 151-157
|
artikel
|
| 25 |
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer
|
Noël, Grégory
|
|
2018
|
52 |
P2 |
p. 66-74
|
artikel
|
| 26 |
The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer
|
Missiaen, Rindert
|
|
2018
|
52 |
P2 |
p. 107-116
|
artikel
|
| 27 |
The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review
|
Butterfield, Lisa H.
|
|
2018
|
52 |
P2 |
p. 12-15
|
artikel
|
| 28 |
Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy
|
Agrawal, Lokesh
|
|
2018
|
52 |
P2 |
p. 26-38
|
artikel
|
| 29 |
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
|
Dieci, Maria Vittoria
|
|
2018
|
52 |
P2 |
p. 16-25
|
artikel
|
Tijdschrift beschrijving